Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments
Objective This study examined real-world treatment patterns and outcomes in patients with melanoma brain metastasis (MBM) treated with first-line immunotherapy consisting of nivolumab plus ipilimumab or anti-programmed death-1 (PD-1) monotherapy (nivolumab or pembrolizumab) or targeted therapy consi...
Saved in:
| Main Authors: | Ning Ning, Sunandana Chandra, Andriy Moshyk, Divya Patel, Isabella C Glitza Oliva, Jennell Palaia, Leon A Sakkal, Natalia Han, Shardul Odak, Jordana K Schmier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/1/e091098.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proceedings of the seventh annual Women in Melanoma Conference
by: Yana G. Najjar, et al.
Published: (2025-06-01) -
Uveal Melanoma Metastasis to the Thyroid
by: Rokshana R. Thanadar, et al.
Published: (2023-01-01) -
Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
by: Wolfram Samlowski, et al.
Published: (2023-02-01) -
Predicting overall survival benefit in previously untreated, unresectable or metastatic melanoma from improvement in progression-free survival: a correlation meta-analysis
by: Peter Mohr, et al.
Published: (2025-06-01) -
Rectal Melanoma with Solitary Pancreatic Metastasis
by: Abhishek Yadav, et al.